GYRE Competitors & Alternatives
Compare Gyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
GYRE
Main Stock$7.25
Tradestie Score
47
Market Cap
$688.47M
Revenue Growth
0.0%
Analyst Upside
+157.5%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KOD
Kodiak Sciences Inc Common Stock
|
$92.21
|
$832.47M | - | 36 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$41.38
|
$824.20M | - | 67 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$3.57
|
$821.84M | - | 58 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$58.25
|
$800.41M | - | 57 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$14.18
|
$799.70M | - | 36 | Compare |
|
KURA
Kura Oncology, Inc.
|
$10.61
|
$798.53M | - | 61 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$11.09
|
$791.82M | - | 48 | Compare |
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$8.15
|
$757.72M | - | 45 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$28.16
|
$748.90M | - | 56 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$17.03
|
$726.21M | 16.4 | 51 | Compare |
More GYRE Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry